Authors:
VILLALONACALERO M
EDER J
TOPPMEYER D
ALLEN L
VELAGAPUDI R
MYERS M
AMATO A
KAGENHALLET K
RAZVILLAS B
OCONNOR L
FRAM R
KUFE D
VONHOFF D
ROWINSKY E
Citation: M. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF LU79553, A NOVEL BIS-NAPHTHALAMIDE ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 249-249
Authors:
RUBIN E
ZAMEK R
MEDINA M
TOPPMEYER D
BUBEN J
PRIEST T
JORDAN C
SLAPAK C
Citation: E. Rubin et al., A PHASE-I DOSE-ESCALATING TRIAL OF LY335979, A POTENT MULTIDRUG-RESISTANCE MODULATOR, COMBINED WITH DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 9, 1998, pp. 553-553
Authors:
VILLALONACALERO MA
BAKER SD
HAMMOND L
AYLESWORTH C
ECKHARDT SG
KRAYNAK M
FRAM R
FISCHKOFF S
VELAGAPUDI R
TOPPMEYER D
RAZVILLAS B
JAKIMOWICZ K
VANHOFF DD
ROWINSKY E
Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779
Authors:
RUBIN E
WOOD V
BHARTI A
TRITES D
LYNCH C
HURWITZ S
BARTEL S
LEVY S
ROSOWSKY A
TOPPMEYER D
KUFE D
Citation: E. Rubin et al., A PHASE-I AND PHARMACOKINETIC STUDY OF A NEW CAMPTOTHECIN DERIVATIVE,9-AMINOCAMPTOTHECIN, Clinical cancer research, 1(3), 1995, pp. 269-276
Authors:
RUBIN E
PANTAZIS P
BHARTI A
TOPPMEYER D
GIOVANELLA B
KUFE D
Citation: E. Rubin et al., IDENTIFICATION OF A MUTANT HUMAN TOPOISOMERASE-I WITH INTACT CATALYTIC ACTIVITY AND RESISTANCE TO 9-NITRO-CAMPTOTHECIN, The Journal of biological chemistry, 269(4), 1994, pp. 2433-2439